1. [Cadmium-induced changes in the activity of the dopaminergic and purinergic systems and in ascorbic acid catabolism in the rat striatum].
- Author
-
Desole MS, Miele M, Esposito G, Fresu L, Enrico P, De Natale G, Anania V, and Miele E
- Subjects
- Adenosine metabolism, Animals, Corpus Striatum metabolism, Dopamine metabolism, Male, Rats, Receptors, Dopamine metabolism, Receptors, Purinergic metabolism, Uric Acid metabolism, Ascorbic Acid metabolism, Cadmium toxicity, Cadmium Compounds, Corpus Striatum drug effects, Receptors, Dopamine drug effects, Receptors, Purinergic drug effects, Sulfates
- Abstract
Levels of dopamine (DA), 3-4-dihydroxyphenylacetic acid (DOPAC), ascorbic acid (AA), dehydroascorbic acid (DHAA), uric acid (UA) and adenosine (ADO), were determined by HPLC in the striatum of male Wistar rats treated with repeated injections of cadmium (as sulfate) 3 mg/kg/day s.c. for 10 consecutive days. Cadmium treatment significantly reduced DOPAC levels with consequent decrease of the DOPAC/DA ratio; AA levels were significantly reduced, while DHAA levels were significantly increased, with consequent increase of DHAA/AA ratio: levels of UA and ADO were both significantly increased. It is concluded that cadmium, given systemically, reduces dopaminergic system activity in the rat striatum; such impairment occurs together with an increase of AA oxidation and of markers of purinergic system activity. The inhibition of striatal dopaminergic activity could be considered the neurochemical basis of behavioral changes induced by cadmium, while the increase of AA oxidation and of purinergic system activity could be considered an antitoxic metabolic response.
- Published
- 1991